Philadelphia / Dublin / Buffalo / Houston / Los Angeles / Toronto / Raleigh / New York / Chicago / /
Company
Fox Chase / Astex Pharmaceuticals Inc. / /
Country
Canada / /
Event
FDA Phase / /
Facility
Temple University / UT MD Anderson Cancer Center / University of Southern California / Princess Margaret Cancer Center / Ohio State University / Roswell Park Cancer Institute / Weill Cornell Medical College / Fox Chase Cancer Center / University of Chicago Medical Center / Duke University Medical Center / Fort Myers / Fels Institute / /
IndustryTerm
treatment of relapsed/refractory Acute Myeloid Leukemia / /
Princess Margaret Cancer Center / The University of Chicago Medical Center / University of Southern California / Fels Institute / Keck School of Medicine / The Ohio State University / Columbus / Temple University / Philadelphia / Duke University Medical Center / Cornell Medical College / Roswell Park Cancer Institute / /
Person
Sue Naim / Eric Feldman / Yong Hao / Karen Yee / Jean Pierre Issa / Scott Lunin / Guillermo Garcia-Manero / Katherine Walsh / Patricia Kropf / Eligibility Criteria / Elizabeth Griffiths / Gail Roboz / Mohammad Azab / Gavin Choy / Elias Jabbour / David Rizzieri / Wendy Stock / /
Position
Major / Florida Cancer Specialist / /
Product
SC / SGI-110 / LINE-1 / /
ProvinceOrState
Texas / Ohio / Pennsylvania / South Carolina / Illinois / Southern California / New York / California / /
2014_SGI-110_poster_ASCO_abst_7030_Griffiths-draft_v6